These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7339704)

  • 1. [Physicochemical processes in human normal immunoglobulin preparations and various related problems].
    Aleksandrowicz J
    Przegl Epidemiol; 1981; 35(4):437-41. PubMed ID: 7339704
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the degree of degradation of human placental immunoglobulin preparations].
    Aleksandrowicz J; Zakrzewska A
    Med Dosw Mikrobiol; 1983; 35(3-4):269-75. PubMed ID: 6374336
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of placental immunoglobulin degradation by lyophilization].
    Iskierko J; Zarnowski J; Prasał Z
    Med Dosw Mikrobiol; 1980; 32(1):69-73. PubMed ID: 7412446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biologically active substances, other than antibodies, in preparations of normal human immunoglobulin. II. Placental proteins].
    Banach W
    Med Dosw Mikrobiol; 1986; 38(4):249-56. PubMed ID: 3561099
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory tests on the stability of biological reference preparations.
    Kirkwood TB
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1987; (80):289-96. PubMed ID: 3688870
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of biotechnological products: stability testing of biotechnological/biological products. Annex to the ICH Harmonised Tripartite Guideline for the Stability Testing of New Drug Substances and Products.
    Dev Biol Stand; 1998; 93():211-9. PubMed ID: 9737398
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the fluorescence in preparations of normal human immunoglobulin during deamidation].
    Lukash AI; Shepelev AP; Al'perovich DV; Pushkina NV; Sherstnev KB
    Antibiot Med Biotekhnol; 1986 Nov; 31(11):848-51. PubMed ID: 3813507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immunoglobulin G fragments in liquid intravenous immunoglobulin products.
    Diemel RV; ter Hart HG; Derksen GJ; Koenderman AH; Aalberse RC
    Transfusion; 2005 Oct; 45(10):1601-9. PubMed ID: 16181211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secretory immune system as part of the placental barrier in the second trimester of pregnancy in humans.
    Ben-Hur H; Gurevich P; Berman V; Tchanyshev R; Gurevich E; Zusman I
    In Vivo; 2001; 15(5):429-35. PubMed ID: 11695242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of control tests of biological products in relation to the use in practice].
    Fernández de Castro J
    Salud Publica Mex; 1979; 21(4):361-8. PubMed ID: 550315
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrastructural evidence of transplacental transport of immunoglobulin G in bitches.
    Stoffel MH; Friess AE; Hartmann SH
    J Reprod Fertil; 2000 Mar; 118(2):315-26. PubMed ID: 10864795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatography in the quality control of immunoglobulin preparations during production and storage.
    Suomela H; Himberg JJ; Kuronen T
    J Chromatogr; 1984 Aug; 297():369-73. PubMed ID: 6490769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of proteolytic enzymes contaminating human placental immunoglobulin preparations].
    Iskierko J; Zarnowski J
    Med Dosw Mikrobiol; 1980; 32(1):63-8. PubMed ID: 6447827
    [No Abstract]   [Full Text] [Related]  

  • 14. [The immuno-pathological damage of placenta and its types in pregnancy induced hypertension].
    Chen H; Huang Y; Ma T
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):540-1. PubMed ID: 9275426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of two IgG subclasses in transport of immunoglobulin across the human placenta.
    Mongan LC; Ockleford CD
    J Anat; 1996 Feb; 188 ( Pt 1)(Pt 1):43-51. PubMed ID: 8655414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering.
    Ahrer K; Buchacher A; Iberer G; Jungbauer A
    J Biochem Biophys Methods; 2006 Mar; 66(1-3):73-86. PubMed ID: 16458360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The placental immunopathology of intrauterine growth retardation].
    Zhang J; Liu Y; Li H
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):202-5. PubMed ID: 11783360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the stability of human immunoglobin preparations from the placenta].
    Aleksandrowicz J; Zakrzewska A
    Med Dosw Mikrobiol; 1981; 33(1):73-81. PubMed ID: 7278431
    [No Abstract]   [Full Text] [Related]  

  • 20. The placental transfer of IgG subclasses in human pregnancy.
    Pitcher-Wilmott RW; Hindocha P; Wood CB
    Clin Exp Immunol; 1980 Aug; 41(2):303-8. PubMed ID: 7438556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.